Cambridge Investment Research Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36K | Sell |
48,773
-3,000
| -6% | -$2.21K | ﹤0.01% | 3560 |
|
|
2025
Q1 | $42K | Buy |
51,773
+3,677
| +8% | +$2.98K | ﹤0.01% | 3420 |
|
|
2024
Q4 | $66K | Buy |
48,096
+32,300
| +204% | +$44.3K | ﹤0.01% | 3358 |
|
|
2024
Q3 | $16K | Sell |
15,796
-3,789
| -19% | -$3.84K | ﹤0.01% | 3376 |
|
|
2024
Q2 | $34K | Sell |
19,585
-5,058
| -21% | -$8.78K | ﹤0.01% | 3244 |
|
|
2024
Q1 | $59K | Sell |
24,643
-180,500
| -88% | -$432K | ﹤0.01% | 3201 |
|
|
2023
Q4 | $683K | Buy |
205,143
+182,061
| +789% | +$606K | ﹤0.01% | 1933 |
|
|
2023
Q3 | $86K | Buy |
23,082
+1,404
| +6% | +$5.23K | ﹤0.01% | 2979 |
|
|
2023
Q2 | $93K | Hold |
21,678
| – | – | ﹤0.01% | 3012 |
|
|
2023
Q1 | $148K | Buy |
21,678
+4,700
| +28% | +$32.1K | ﹤0.01% | 2904 |
|
|
2022
Q4 | $134K | Buy |
16,978
+1,800
| +12% | +$14.2K | ﹤0.01% | 2856 |
|
|
2022
Q3 | $146K | Sell |
15,178
-400
| -3% | -$3.85K | ﹤0.01% | 2788 |
|
|
2022
Q2 | $113K | Hold |
15,578
| – | – | ﹤0.01% | 2846 |
|
|
2022
Q1 | $201K | Hold |
15,578
| – | – | ﹤0.01% | 2871 |
|
|
2021
Q4 | $249K | Sell |
15,578
-1,800
| -10% | -$28.8K | ﹤0.01% | 2696 |
|
|
2021
Q3 | $279K | Sell |
17,378
-200
| -1% | -$3.21K | ﹤0.01% | 2523 |
|
|
2021
Q2 | $243K | Buy |
+17,578
| New | +$243K | ﹤0.01% | 2649 |
|